Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors

被引:0
|
作者
A M Shaw
G L Joseph
A C Jasti
L Sastry-Dent
S Witting
K Cornetta
机构
[1] Indiana University School of Medicine,Departments of Medical and Molecular Genetics
[2] Indiana University School of Medicine,Departments of Microbiology
[3] Cincinnati Children’s Hospital,Department of Experimental Hematology and Cancer Biology
[4] Indiana University School of Medicine,Departments of Medicine
来源
Gene Therapy | 2017年 / 24卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A variety of mutations in lentiviral vector expression systems have been shown to generate a non-integrating phenotype. We studied a novel 12 base-pair U3-long terminal repeats (LTR) integrase (IN) attachment site deletion (U3-LTR att site) mutant and found similar physical titers to the previously reported IN catalytic core mutant IN/D116N. Both mutations led to a greater than two log reduction in vector integration; with IN/D116N providing lower illegitimate integration frequency, whereas the U3-LTR att site mutant provided a higher level of transgene expression. The improved expression of the U3-LTR att site mutant could not be explained solely based on an observed modest increase in integration frequency. In evaluating processing, we noted significant differences in unintegrated vector forms, with the U3-LTR att site mutant leading to a predominance of 1-LTR circles. The mutations also differed in the manner of illegitimate integration. The U3-LTR att site mutant vector demonstrated IN-mediated integration at the intact U5-LTR att site and non-IN-mediated integration at the mutated U3-LTR att site. Finally, we combined a variety of mutations and modifications and assessed transgene expression and integration frequency to show that combining modifications can improve the potential clinical utility of non-integrating lentiviral vectors.
引用
收藏
页码:12 / 20
页数:8
相关论文
共 50 条
  • [1] Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors
    Shaw, A. M.
    Joseph, G. L.
    Jasti, A. C.
    Sastry-Dent, L.
    Witting, S.
    Cornetta, K.
    GENE THERAPY, 2017, 24 (01) : 12 - 20
  • [2] Non-Integrating Lentiviral Vectors
    Sarkis, Chamsy
    Philippe, Stephanie
    Mallet, Jacques
    Serguera, Che
    CURRENT GENE THERAPY, 2008, 8 (06) : 430 - 437
  • [3] Optimizing Expression and Minimizing Integration in Non-Integrating Lentiviral Vectors
    Shaw, Aaron
    Cornetta, Kenneth
    MOLECULAR THERAPY, 2014, 22 : S289 - S289
  • [4] Non-integrating lentiviral vectors for immunization
    Karwacz, Katarzyna
    Apolonia, Luis
    Escors, David
    Lopes, Luciene
    Collins, Mary K.
    HUMAN GENE THERAPY, 2007, 18 (10) : 1019 - 1019
  • [5] Non-Integrating Lentiviral Vectors for Vaccination
    Karwacz, Katarzyna
    Apolonia, Luis
    Escors, David
    Thrasher, Adrian
    Collins, Mary
    MOLECULAR THERAPY, 2009, 17 : S91 - S91
  • [6] Design and Potential of Non-Integrating Lentiviral Vectors
    Shaw, Aaron
    Cornetta, Kenneth
    BIOMEDICINES, 2014, 2 (01): : 14 - 35
  • [7] Development of Non-Integrating and Site-Specifically Integrating Lentiviral Vectors
    Apolonia, Luis
    Waddington, Simon
    Collins, Mary
    Thrasher, Adrian
    Philpott, Nicola
    MOLECULAR THERAPY, 2006, 13 : S177 - S177
  • [8] Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
    Gurumoorthy, Narmatha
    Nordin, Fazlina
    Tye, Gee Jun
    Wan Kamarul Zaman, Wan Safwani
    Ng, Min Hwei
    BIOMEDICINES, 2022, 10 (01)
  • [9] Transient gene expression by Non-Integrating Lentiviral (NIL) vectors
    Nightingale, S
    Hollis, RP
    Yang, C
    Bahner, I
    Pepper, KA
    Kohn, DB
    MOLECULAR THERAPY, 2004, 9 : S159 - S160
  • [10] Non-Integrating Polycistronic Lentiviral Vectors for Use in the Central Nervous System
    Gonitel, Roman
    Acosta-Saltos, Carolina
    T, Mary Joy
    Anderson, Patrick
    Raivich, Gennadij
    Thrasher, Adrian
    HUMAN GENE THERAPY, 2010, 21 (04) : 511 - 512